← Leaderboards
Simon C Robson
Massachusetts General Hospital
$16,000,011
Attributed
$16,447,125
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$16,447,125 · 12
By mechanism
P01$5,751,156 · 5
R01$5,331,306 · 3
U01$4,065,493 · 1
R21$1,299,170 · 3
Top collaborators
- David E Avigan2 shared
- Robina Matyal2 shared
Others in their field
Top investigators on “Thrombosis”
- Paul M. Ridker · Brigham And Women'S Hospital$59,264,235
- John H Griffin · Scripps Research Institute$29,245,116
- David J. Pinsky · University Of Michigan At Ann Arbor$29,054,903
- Bruce Furie · Beth Israel Deaconess Medical Center$28,093,838
- Denisa D Wagner · Boston Children'S Hospital$24,247,974
- Satya P. Kunapuli · Temple University$22,403,131
Research focus
ThrombosisPlatelet ActivationBlood VesselsVascular EndotheliumCellsMediatingInjuryThromboplastinNucleotidesResponseInflammatoryNucleoside TriphosphateInflammationIn VivoExtracellularMolecularMediator Of Activation ProteinLaboratory MouseBlood PlateletsOrganThrombomodulinAcuteLinkMutant
Grant awards (50)
PGC-1α, Purines and the Postmenopausal Heart$262,500
R21 · FY2022 · AG
PGC-1α, Purines and the Postmenopausal Heart$218,750
R21 · FY2021 · AG
Directed Purinergic Signaling as Immunotherapy in Leukemia$184,603
R21 · FY2019 · CA · contact PI
Directed Purinergic Signaling as Immunotherapy in Leukemia$228,375
R21 · FY2018 · CA · contact PI
Thromboregulatory Barriers to Xenotransplantation$257,704
P01 · FY2015 · AI · contact PI
Thromboregulatory Barriers to Xenotransplantation$181,719
P01 · FY2014 · AI · contact PI
Thromboregulatory Barriers to Xenotransplantation$242,732
P01 · FY2013 · AI · contact PI
Engineering Inhibitory Antibodies to Ectoenzymes for Cancer Treatment$177,872
R21 · FY2013 · CA · contact PI
Thromboregulatory Barriers to Xenotransplantation$271,758
P01 · FY2012 · AI · contact PI
Engineering Inhibitory Antibodies to Ectoenzymes for Cancer Treatment$227,070
R21 · FY2012 · CA · contact PI
Thromboregulatory Barriers to Xenotransplantation$327,650
P01 · FY2011 · AI · contact PI
Purinergic Thromboregulation$637,500
R01 · FY2010 · HL · contact PI
Thromboregulatory strategies to prolong xenograft survival.$982,867
U01 · FY2009 · AI · contact PI
Purinergic Thromboregulation$737,500
R01 · FY2009 · HL · contact PI
Thromboregulatory strategies to prolong xenograft survival.$645,765
U01 · FY2009 · AI · contact PI
Thromboregulatory Barriers to Xenotransplantation$334,814
P01 · FY2009 · AI · contact PI
Thromboregulatory strategies to prolong xenograft survival.$635,913
U01 · FY2008 · AI · contact PI
Thromboregulatory Barriers to Xenotransplantation$327,027
P01 · FY2008 · AI · contact PI
VASCULAR TOPOGRAPHY OF CD39/NTPDASES$315,659
P01 · FY2008 · HL · contact PI
CORE--HISTOLOGICAL SUPPORT$76,610
P01 · FY2008 · HL · contact PI
Thromboregulatory strategies to prolong xenograft survival.$638,482
U01 · FY2007 · AI · contact PI
VASCULAR TOPOGRAPHY OF CD39/NTPDASES$365,618
P01 · FY2007 · HL · contact PI
Thromboregulatory Barriers to Xenotransplantation$273,309
P01 · FY2007 · AI · contact PI
Functional Analysis of Vascular NTPDases$241,786
R01 · FY2007 · HL · contact PI
CORE--HISTOLOGICAL SUPPORT$88,105
P01 · FY2007 · HL · contact PI
Thromboregulatory strategies to prolong xenograft survival.$595,760
U01 · FY2006 · AI · contact PI
VASCULAR TOPOGRAPHY OF CD39/NTPDASES$360,708
P01 · FY2006 · HL · contact PI
Thromboregulatory Barriers to Xenotransplantation$331,024
P01 · FY2006 · AI · contact PI
Functional Analysis of Vascular NTPDases$249,008
R01 · FY2006 · HL · contact PI
CORE--HISTOLOGICAL SUPPORT$86,567
P01 · FY2006 · HL · contact PI
Thromboregulatory strategies to prolong xenografts$566,706
U01 · FY2005 · AI
VASCULAR TOPOGRAPHY OF CD39/NTPDASES$352,202
P01 · FY2005 · HL
Functional Analysis of Vascular NTPDases$255,000
R01 · FY2005 · HL
Thromboregulatory Barriers to Xenotransplantation$163,579
P01 · FY2005 · AI
CORE--HISTOLOGICAL SUPPORT$84,048
P01 · FY2005 · HL
VASCULAR NTPDASES AND TRANSPLANTATION$391,500
R01 · FY2004 · HL
VASCULAR TOPOGRAPHY OF CD39/NTPDASES$340,000
P01 · FY2004 · HL
Functional Analysis of Vascular NTPDases$255,000
R01 · FY2004 · HL
CORE--HISTOLOGICAL SUPPORT$81,600
P01 · FY2004 · HL
VASCULAR NTPDASES AND TRANSPLANTATION$391,500
R01 · FY2003 · HL
FUNCTIONAL ANALYSIS OF VASCULAR NTPDASES$261,000
R01 · FY2003 · HL
VASCULAR NTPDASES AND TRANSPLANTATION$391,500
R01 · FY2002 · HL
THROMBOREGULATORY BARRIERS TO XENOTRANSPLANTATION$296,241
P01 · FY2002 · AI
FUNCTIONAL ANALYSIS OF VASCULAR NTPDASES$261,000
R01 · FY2002 · HL
VASCULAR NTPDASES AND TRANSPLANTATION$391,500
R01 · FY2001 · HL
THROMBOREGULATORY BARRIERS TO XENOTRANSPLANTATION$296,241
P01 · FY2001 · AI
FUNCTIONAL ANALYSIS OF VASCULAR NTPDASES$261,000
R01 · FY2001 · HL
VASCULAR ECTO ADPASES AND TRANSPLANTATION$345,512
R01 · FY2000 · HL
THROMBOREGULATORY BARRIERS TO XENOTRANSPLANTATION$296,241
P01 · FY2000 · AI
FUNCTIONAL ANALYSIS OF VASCULAR NTPDASES$261,000
R01 · FY2000 · HL